Authors: van der Meer H van Zwol A Spanjaard L van Furth M
Address: VU medisch centrum, Amsterdam, Afd. Intensive Care kinderen, the Netherlands. h.vandermeer@vumc.nl
Journal:
Publication:
abstractBACKGROUND:
Following the introduction of a heptavalent pneumococcal conjugate vaccine (PCV7) in the Netherlands in 2006, the incidence of invasive pneumococcal disease (IPD) declined significantly. Since then a shift towards non-vaccine serotype IPD has been noted.
CASE DESCRIPTION:
We present the case of multidrug resistant non-vaccine serotype 19A pneumococcal meningitis in a 5-month-old boy. He was admitted to our Paediatric Intensive Care Unit (PICU) with seizures and septic shock. A barbiturate-induced coma was eventually required to control the seizures; shock was combated with intravenous fluids and inotropes. He received a 6-week course of ceftriaxone and vancomycin. At follow-up, one year after discharge, he had unilateral deafness and minor developmental delay.
CONCLUSION:
Worldwide, pneumococcal serotype 19A is now the most common cause of IPD in children, with an increasing incidence of multidrug resistant strains. This trend has not yet been observed in the Netherlands. This case demonstrates that even following the introduction of PCV7 pneumococcal meningitis can still occur. Prompt recognition of the symptoms is still essential.
Related ArticlesEpidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.Pediatr Infect Dis J. 2010
Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.
Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R, McCracken GH Jr. Pediatr Infect Dis J. 2010 Apr; 29(4):294-300.
Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.Pediatr Infect Dis J. 2010
Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007.
Hsu KK, Shea KM, Stevenson AE, Pelton SI, Massachusetts Department of Public Health. Pediatr Infect Dis J. 2010 Apr; 29(4):289-93.
Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.Pediatr Infect Dis J. 2007
Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine.
Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenberg J, Huang SS, Goldstein R, Hanage WP. Pediatr Infect Dis J. 2007 Jun; 26(6):468-72.
Review Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.Clin Microbiol Infect. 2009
Review Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.
Dagan R. Clin Microbiol Infect. 2009 Apr; 15 Suppl 3:16-20.
Review Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.Int J Infect Dis. 2010
Review Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
Isaacman DJ, McIntosh ED, Reinert RR. Int J Infect Dis. 2010 Mar; 14(3):e197-209. Epub 2009 Aug 22.
To
top
•
Home
Show
map | Diseases | Vaccination
| Chronic disease | Medicine
| Pregnancy
| Heat & Sunburn | Cold | Security
| Useful tips | Faq
| News
TraveldoctorOnline 2001 •
Disclaimer • webmaster